Trademarkia Logo

Canada

C$
Trademark Search in Canada
NUGALVIQ

View On IC.GC.CA

NUGALVIQ
ADVERTISED

on 9 Apr 2025

Last Applicant/ Owned by

Applied Therapeutics, Inc

545 Fifth Avenue, Suite 1400New York, NY 10017

US

Serial Number

2117762 filed on 30th Jun 2021

Correspondent Address

SMART & BIGGAR LP

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

NUGALVIQ

Trademark usage description

pharmaceutical preparations for inhibiting aldose reductase; pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (sord) Read More

Classification Information

Class [005]
Pharmaceutical preparations for inhibiting aldose reductase; pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) and PMM2-congential disorder of glycosylation (PMM2-CDG)

Classification kind code

11

Mark Details

Serial Number

2117762

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 9th Apr 2025		Advertised
Submitted for opposition 27
on 6th Mar 2025		Approval Notice Sent
Submitted for opposition 26
on 6th Mar 2025		Approved
Submitted for opposition 22
on 29th Nov 2024		Search Recorded
Submitted for opposition 20
on 29th Nov 2024		Examiner's First Report
Submitted for opposition 67
on 27th Sept 2024		Agent Name Changed
Submitted for opposition 287
on 6th Jul 2022		Pre-Assessment Letter Sent
Submitted for opposition 30
on 30th Jun 2021		Filed
Submitted for opposition 1
on 30th Jun 2021		Created
Submitted for opposition 31
on 30th Jun 2021		Formalized